5-(4-Methoxyphenoxy)-1,3-dihydro-2-benzofuran-1-one, 99.0%, 25g

2-amino-N-(2-phenylethyl)acetamide hydrochloride, 95.0%, 500mg

2-(3-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

Ethyl 2-cyano-3-phenylacrylate, 95.0%, 5g

1,4-Dibenzyl L-Aspartate p-Toluenesulfonate>97.0%(HPLC)(N)(T)25g

3-N-Boc-3-Methylbutane-1,3-diamine hydrochloride, 95.0%, 100mg

N-Cyano-4-methyl-N-phenylbenzenesulfonamide, 95.0%, 25g

1-(2,6-Dichlorophenyl)ethanamine hydrochloride, 95.0%, 100mg

4-Aminopicolinic acid hydrochloride, 95.0%, 25g

2-(4-Methoxyphenyl)-2-methylpropanenitrile, 97.0%, 250mg

Plan phase PLPHi 10x/0.25 infinity corrected IOS objective. Working distance 5.00 mm

6-Chloro-4-methoxypicolinonitrile, 95.0%, 250mg

3-(Methoxycarbonyl)-5-nitrobenzoic acid, 95.0%, 5g